Summary.-The present study of the effect of heparin and dextran 1000 on the metastasis formation after i.v. tumour cell injection in dextran non-sensitive rats using a syngeneic 20-methylcholanthrene induced fibrosarcoma showed that heparin treatment decreased the formation of pulmonary metastases in animals both untreated and treated with dextran 1000. Treatment with dextran 1000 increased the formation of pulmonary metastases in animals both untreated and treated with heparin and the effect of dextran 1000 was thus not affected by heparin treatment. Heparin did not have any direct action on the tumour cells, which influenced metastasis formation. The data suggest that heparin acts as an anticoagulant with decreased microthrombus formation around lodged cells and that dextran 1000 stimulates metastasis formation primarily by mechanisms other than intravascular coagulation.
DIFFERENT kinds of trauma stimulate metastasis formation after i.v. tumour cell injection (Agostino and Clifton, 1965; Boeryd and Rudenstam, 1967; Fisher and Fisher, 1959; Gelin and Rudenstam, 1966; el Rifi et al., 1965; Rudenstam, 1968; Wood, Holyoke and Yardley, 1961) .
Intravascular coagulation is one of several post-traumatic reactions, which has been considered responsible for this effect of trauma Gelin and Rudenstam, 1966; Robinson and Hoppe, 1962; Rudenstam, 1968; Wood et al., 1961) . Therefore it has seemed logical to counteract the effect of trauma on metastasis formation by the use of anticoagulants. In earlier studies Rudenstam (1968) used heparin in combination with a crush fracture trauma, but no conclusive results were obtained because a lot of animals deteriorated or died from severe bleedings in the traumatized region.
Like trauma, intravenous infusion of high molecular weight dextran (dextran 1000, mean molecular weight about 1,000,000) induces intravascular coagulation and increased tendency to thrombus formation (Bergentz, Eiken and Nilsson, 1 971; Borgstrom, Gelin and Zederfeldt, 1959; Rudenstam, 1968) . Rudenstam (1968) used dextran 1000 to imitate the post-traumatic coagulation disturbances and found that dextran 1000 increased the formation of pulmonary metastases after i.v. tumour cell injection. Heparin reduced the formation of metastases in both untreated animals and animals given infusion of dextran 1000. However, heparin counteracted the stimulating effect of dextran 1000 on metastasis formation only partially. This suggested that also mechanisms other than intravascular coagulation, such as disturbed microcirculation and the anaphylactoid reaction to dextran, could be of importance for the enhanced formation of metastases after infusion of dextran 1000. In Rudenstam's experiments Sprague-Dawley rats were used. These rats all developed an anaphylactoid reaction against dextran, which thus might have interfered with the results.
In the present study dextran nonsensitive rats were used. and fluorescein dextran tests (Arfors, 1972) give any evidence for dextran sensitivity, when performed on these rats after infusion of dextran.
Tumour. (Boeryd, 1965; Boeryd et al., 1966) . Since these values were distributed in a log-normal way Rudenstam, 1968 ) the statistical calculations were performed on their log-values and the median values are given in the tables where V= median total metastasis volume in cm3 per cm3 lung tissue N = median number of metastases per cm3 lung tissue v = median average volume of a single metastasis in cm3
The number of animals with pulmonary metastases out of the total number of animals in an experimental group was recorded as the incidence of pulmonary metastases.
In the first experiment (A) the lung weights also were recorded.
Statistical methods.-When comparing the lung weight, the volume and the number of metastases in a control and an experimental group Student's t-test was used. When 2 experimental groups were compared, a variance analysis was performed and differences between the groups were analysed according to Scheff6.
All statistical analyses in this investigation were carried out at a 5% level of significance, i. In Group 2 and 4 animals received 200 i.u. of heparin in a volume of 0-1 ml/100 g body weight. The dosage of heparin used was known to give a coagulation time of more than 30 min for at least 24 h (Rudenstam, 1968) . In Groups 1 and 3, saline was given in a dose of 0-1 ml/100 g body weight to equal the volume of heparin given in Groups 2 and 4. The glucose solution was 5-5% and the dose given was 0-75 ml/100 g body weight. All i.v. injections were given into a tail vein.
The tumour used was in its 18th transfer generation. An enzyme disintegrated cell suspension was prepared as earlier described Group 2.-These animals received tumour cells which had been incubated after the addition of heparin to the cell suspension intravenously.
The tumour used was in its 29th transfer generation. An enzyme disintegrated tumour cell suspension was prepared as before and divided into 2 equal parts. To one of this 20 i.u. of heparin/ml suspension was added. This amount of heparin gave a concentration in the suspension which equalled that in the blood after injection of 200 i.u. of heparin/lO0 g body weight. Both suspensions were incubated for 30 min at 37°C. The cell viability in the suspensions was tested with nigrosin after the incubation period and was about 90%. The animals in the first group were injected i.v. with 6 x 104 cells from the untreated tumour cell suspension and the animals in the second group were injected i.v. with 5-5 x 104 cells from the heparin treated tumour cell suspension. All injections were given into a tail vein. All animals were killed after 20 days by exsanguination following cannulation of the aorta under ether anaesthesia.
RESULTS
A. The mean lung weight, the incidence of metastases, the median total metastasis volume, the median number of metastases and the median average volume of a single metastasis are presented in Table I .
The lung weight was significantly decreased by heparin and significantly increased by dextran 1000. The combined treatment did not change the lung weight compared with controls. The incidence of metastases was 100 % in all groups.
The total metastasis volume was significantly decreased by heparin but was not influenced significantly by dextran 1000 or the combined treatment. The number of metastases was significantly decreased by heparin and significantly increased by dextran 1000, whereas the combined treatment did not influence the number of metastases in a significant way. The average metastasis volume was not sig- nificantly influenced by any kind of treatment.
When the effect of dextran 1000 in animals treated with heparin was analysed (heparin compared with heparin + dextran 1000) it was evident that both the total metastasis volume and the number of metastases were significantly increased by dextran 1000. On the other hand, heparin treatment decreased the lung weight, the total metastasis volume and the number of metastases significantly in animals given dextran 1000 (dextran 1000 compared with heparin + dextran 1000). No extrapulmonary metastases were observed.
B. The incidence of metastases, the total metastasis volume, the number of metastases and the average volume of a single metastasis are presented in Table II .
There were no differences between the 2 groups in any of the recorded parameters and no extrapulmonary metastases were observed. Thus, pretreatment of tumour cells with heparin did not influence the formation of metastases. These results are in agreement with most earlier reports on the effect of shortterm heparin treatment in both allogeneic and syngeneic tumour-host systems Cliffton, 1962, 1965; Cliffton and Agostino, 1965;  Koike, 1963; Lawrence, Moor and Bernstein, 1953; el Rifi et al., 1965; Rudenstam, 1968; Suemasu and Ishikawa, 1970; Wood et al., 1961) . The incidence and number of extrapulmonary metastases were investigated especially in some of the studies mentioned, and were not influenced by heparin treatment (el Rifi et al., 1965; Rudenstam, 1968; Wood et al., 1961) or increased (Lawrence et al., 1953) . Koike (1963) and Wood et al. (1961) also studied the effect of incubation of tumour cells with heparin before tumour cell injection and did not find any effect of this procedure. Pretreatment with anticoagulants such as warfarin and dicoumarol was found to decrease pulmonary metastasis formation after i.v. tumour cell injection Wood et al., 1961) .
DISCUSSION
It is well documented that after the initial adherence to the vascular endothelium intravenously injected tumour cells are promptly entrapped by thrombi composed of platelets and fibrin or a fibrin-like protein (Gastpar et al., 1961; Jones, Wallace and Fraser, 1971; Wood, 1958) . This microthrombus is considered by many to be an important and perhaps necessary prerequisite for the development of lodged tumour cells into metastases (Gastpar, 1970; Strauli, 1966; Suemasu and Ishikawa, 1970; Wood, 1958) . Heparin is supposed to inhibit this microthrombus formation. It has therefore been assumed that the effect of heparin on metastasis formation is due mainly to its anticoagulant ptoperties.
However, other opinions have also been presented. Boeryd (1965, 1966a,b, c) concluded that thrombus formation did not seem to be essential for metastasis formation and growth. The same opinion was expressed by Hagmar and Boeryd (1969) . They found that thrombus formation seemed rather to inhibit the establishment of metastases. Later, Hagmar and Norrby (1970) arrived at the opinion that heparinprobablyinfluenced metastasis formation by mechanisms other than that of impaired blood coagLlation. Heparin is a potent surfactant. It is known that heparin can alter membrane functions and cellular volume (Ambrose, 1967) , electrophoretic mobility, adhesiveness and possibly the deformation of cells (Nordling, 1967) , ability of cells to aggregate (Ambrose, Easty and Jones, 1968) and contact between lymphocytes and target cells (Taylor and Culling, 1966) . Such changes might lead to decreased lodgement of tumour cells in the pulmonary circulation. As pointed out above, however, no evidence of such an effect of heparin influencing metastasis formation was obtained in this study and in studies of Wood et al. (1961) and Koike (1963) .
If heparin counteracts the microthrombus formation around lodged tumour cells, a decreased lodgement of tumour cells and possibly also an increased number of circulating tumour cells might be expected after heparin treatment of animals given tumour cells i.v. Koike (1963) also found an increased number of tumour cells in the blood after heparin treatment and i.v. tumour cell injection, and Suemasu and Ishikawa (1970) found that tumour cells passed through the lung more rapidly and that more tumour cells were found in the circulating blood after heparin treatment.
Heparin treatment did not influence the stimulating effect of dextran 1000 on metastasis formation. This was evident from the effect of dextran 1000 when given to untreated and heparin treated animals. In both these cases the formation of metastases was significantly increased when compared with control resp. heparin treatment alone. This suggested that intravascular coagulation induced by dextran 1000 could not be an important factor behind the stimulation of metastasis formation. Other effects of dextran 1000, such as disturbed microcirculation and/or aggregation of circulating tumour cells, probably were more important for the increased metastasis formation than disturbed coagulation.
Dextran 1000, when given alone, increased the lung weight and the number of metastases significantly but did not increase the total metastasis volume significantly. This possibly depends on the fact that the number of metastases was very large, which might cause a slowing down of growth.
In Rudenstam's studies (1968) dextran 1000 almost always had a more pronounced effect than in this experiment. This can probably be explained by the anaphylactoid reaction which all rats developed and which ought to have potentiated the effect of dextran 1000. When given to mice which did not develop any visible signs of an anaphylactoid reaction, the effect of dextran 1000 on metastasis formation was about the same as in this study. Rudenstam found that heparin in some tumour-host systems partially counteracted the effect of dextran 1000 on metastasis formation. This can possibly be explained by an inhibiting effect of heparin on the intravascular coagulation, being part of the anaphylactoid reaction.
It is important to point out that the variable results obtained from different studies could depend on rather different characteristics of the many tumour-host systems used, on different ways of administration of cells and drugs and on variation of doses of cells and drugs given. This study was supported by the Swedish Cancer Society.
